A detailed history of Berry Wealth Group, LP transactions in Abb Vie Inc. stock. As of the latest transaction made, Berry Wealth Group, LP holds 2,448 shares of ABBV stock, worth $433,173. This represents 0.35% of its overall portfolio holdings.

Number of Shares
2,448
Previous 2,384 2.68%
Holding current value
$433,173
Previous $409 Million 18.23%
% of portfolio
0.35%
Previous 0.33%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$163.84 - $199.33 $10,485 - $12,757
64 Added 2.68%
2,448 $483 Million
Q2 2024

Jul 31, 2024

BUY
$154.79 - $180.76 $55,105 - $64,350
356 Added 17.55%
2,384 $409 Million
Q1 2024

Apr 22, 2024

BUY
$159.82 - $182.1 $324,114 - $369,298
2,028 New
2,028 $369 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $313B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Berry Wealth Group, LP Portfolio

Follow Berry Wealth Group, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Berry Wealth Group, LP, based on Form 13F filings with the SEC.

News

Stay updated on Berry Wealth Group, LP with notifications on news.